Article
The impact of clinical genome sequencing in a global population of patients with suspected rare genetic disease
2023-08-04
Abstract excerpt
<title>Abstract</title> <p>Clinical genome sequencing (cGS) holds promise as a unified diagnostic testing platform in patients with a suspected rare genetic disease (RGD), however its performance and impact on clinical management in a diverse global population has yet to be investigated. The iHope program established a network of 24 clinical sites in eight countries to provide cGS to individuals with signs or sym...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4a9a2ac9-91ad-5382-a230-01fb69fb280a
- DOI
- 10.21203/rs.3.rs-3117254/v1
